Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole

BACKGROUND: Obesity is associated with a risk of gastroesophageal reflux disease. The pharmacodynamic efficacy of proton pump inhibitors has not been specifically evaluated in obese subjects. The aim of this study was to compare the antisecretory response to a single oral dose of 20 mg rabeprazole,...

Descripción completa

Detalles Bibliográficos
Autores principales: Belhocine, Kafia, Vavasseur, Fabienne, Volteau, Christelle, Flet, Laurent, Touchefeu, Yann, Bruley des Varannes, Stanislas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110066/
https://www.ncbi.nlm.nih.gov/pubmed/25027286
http://dx.doi.org/10.1186/1471-230X-14-128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110066/
https://www.ncbi.nlm.nih.gov/pubmed/25027286
http://dx.doi.org/10.1186/1471-230X-14-128

Ejemplares similares